Prognosis Biotech SA Company experts, on 15th October 2024, trained PHPT staff on current Quantum Mycotoxins technologies designed to quantify mycotoxins at very low concentrations in grains, cereals and nuts. This is based on ELISA kits and Lateral-flow tests.

Prognosis Biotech SA company is specialized in developing and manufacturing modern in-vitro testing technologies for use in the food, beverages, agriculture and clinical diagnostic markets.